News
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
29 May 24
Analyst Ratings
Stephens & Co. Reiterates Equal-Weight on Anika Therapeutics, Maintains $24 Price Target
29 May 24
News, Price Target, Reiteration, Analyst Ratings
Barrington Research Maintains Outperform on Anika Therapeutics, Maintains $37 Price Target
9 May 24
News, Price Target, Analyst Ratings
Anika Says Cost Reduction Initiatives Complete; Says On-Track For FY24 Revenue Guidance Of $168M-$173M (Est $170.272M)
8 May 24
News, Guidance
Anika Announces Steve Griffin Appointed To CFO, Effective June 3, 2024
8 May 24
News, Management
Anika Therapeutics Q1 2024 Adj EPS $0.09 Beats $(0.19) Estimate, Sales $40.523M Beat $39.143M Estimate
8 May 24
Earnings, Earnings Beats, News
Press releases
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7 Jun 24
Markets, Press Releases
Anika Enters into Cooperation Agreement with Caligan Partners
28 May 24
News, Financing, Management, Press Releases
Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal®, Monovisc®, and Orthovisc®
16 May 24
News, Contracts, Press Releases
Anika Announces CFO Transition
8 May 24
News, Management, Press Releases
Anika Reports First Quarter 2024 Financial Results
8 May 24
Earnings, Press Releases
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 May 24
Press Releases
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
2 Apr 24
News, Press Releases